Device Patents : These cover the mechanical sub-parts of the injector pens
If you make a product that is a peptide that needs to go into an injection, thats a big manufacturing process, whereas if you made a small molecule that could be a tablet, thats something that could be scaled much faster, he explained
If passed, TROA would: Permanently allow Medicare Part D to cover FDA-approved anti-obesity medications Expand Medicare Part B coverage of intensive behavioral therapy for obesity to include a wider range of providers (not just primary care physicians) However, in April 2025, CMS announced it would not include Medicare Part D coverage of obesity drugs in its rule changes for 2026, stating the proposal was "not appropriate at this time." That decision pushed the issue back to Congress, where the TROA remains under consideration
You need electrolytes too
Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men
